PFIZER CONSUMER HEALTHCARE
Get an alert when PFIZER CONSUMER HEALTHCARE files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Confirmation statement due
2027-04-13 (in 11mo)
Last made up 2026-03-30
Watchouts
Cash
£246K
0% vs 2023
Net assets
£5M
+3.7% vs 2023
Employees
0
Average over period
Profit before tax
£222K
+2.3% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The directors have not prepared these financial statements on a going concern basis as they do not believe it is appropriate to do so; this is detailed further in the statement of accounting policies. As the company has not acquired a replacement trade, in line with the requirements of FRS 102, the directors have prepared the financial statements on a basis other than going concern from 2018 onwards.
Name history
Renamed 3 times since incorporation
- PFIZER CONSUMER HEALTHCARE 2019-05-24 → present
- PFIZER CONSUMER HEALTHCARE LIMITED 2010-03-22 → 2019-05-24
- WHITEHALL LABORATORIES LIMITED 1990-05-06 → 2010-03-22
- INTERNATIONAL CHEMICAL COMPANY,LIMITED 1913-11-06 → 1990-05-06
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-11-30
| Metric | Trend | 2023-11-30 | 2024-11-30 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£141,000 | -£14,000 | |
| Profit before tax | £217,000 | £222,000 | |
| Net profit | £176,000 | £167,000 | |
| Cash | £246,000 | £246,000 | |
| Total assets less current liabilities | £4,571,000 | £4,739,000 | |
| Net assets | £4,570,000 | £4,738,000 | |
| Equity | £4,570,000 | £4,738,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-11-30 | 2024-11-30 |
|---|---|---|---|
| Return on capital employed | -3.1% | -0.3% | |
| Interest cover | -0.31x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The directors have not prepared these financial statements on a going concern basis as they do not believe it is appropriate to do so; this is detailed further in the statement of accounting policies. As the company has not acquired a replacement trade, in line with the requirements of FRS 102, the directors have prepared the financial statements on a basis other than going concern from 2018 onwards.”
Significant events
- “On 19 December 2018 Pfizer Inc., the company's ultimate parent, announced a proposal to enter into an agreement with GSK plc to create a consumer healthcare joint venture. Subsequent to this, during 2019, the company agreed to transfer a portion of its consumer healthcare business and related net assets to PF Consumer Healthcare UK Limited. Separately on 1 July 2019, the company agreed to transfer its remaining business operations to fellow group undertaking Upjohn UK Limited. The completion of these transactions occurred in 2020, when legal title to the assets and liabilities related to the business operations transferred.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 46 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HIGHTON, David Ian | Director | 2021-02-08 | Jul 1968 | British |
| PEARSON, Edwin James | Director | 2017-01-09 | Jan 1974 | British |
| SAINSBURY, Sarah Louise | Director | 2024-05-01 | Aug 1971 | British |
Show 46 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COOKE, Colin Michael | Secretary | — | 1993-07-31 |
| HOLGATE, Benjamin James Michael | Secretary | 2009-10-08 | 2010-02-01 |
| MCEVOY, Liam Francis | Secretary | 1996-02-19 | 2009-09-30 |
| MOUNT, Jacqueline Ann | Secretary | 2012-02-24 | 2021-01-21 |
| REACHER, Paul Anthony | Secretary | 1993-07-31 | 1996-02-19 |
| BEAUCHAMP, David Albert | Director | — | 2003-11-30 |
| BLACKBURN, Richard Neville | Director | 2009-11-04 | 2012-01-01 |
| BROWN, Katherine Mary | Director | 2004-05-13 | 2007-04-30 |
| CALDINI, Peter | Director | 2015-02-25 | 2016-05-15 |
| CANAVAN, Bernard, Doctor | Director | — | 1994-01-31 |
| CLARK, Graham Arthur | Director | 1996-02-19 | 2004-08-03 |
| COATES EVANS, Mark Anthony | Director | 2004-05-13 | 2007-04-10 |
| COLES, Ruth Amy | Director | 2011-04-27 | 2015-07-24 |
| COLGAN, Thomas Augustine | Director | 1994-11-30 | 2003-07-30 |
| COOKE, Colin Michael | Director | — | 1993-07-31 |
| COOPER, Mark | Director | 2003-09-17 | 2004-03-26 |
| DAVIDSON, Mark Wayne | Director | 2017-07-03 | 2020-04-26 |
| EDWARDS, Raymond | Director | — | 1996-10-31 |
| EMMS, Jonathan Charles | Director | 2012-01-01 | 2015-01-31 |
| EVA, Gerald | Director | — | 2005-08-01 |
| FRANKLIN, Ian Eric | Director | 2009-11-04 | 2021-02-09 |
| HARNETT, Denise Jean | Director | 2018-04-26 | 2024-05-01 |
| HAWKINS, Paul Stanley | Director | — | 2005-02-28 |
| HOLGATE, Benjamin James Michael | Director | 2001-10-03 | 2010-04-05 |
| HONEYBOURNE, Robert Noel Travers | Director | — | 2007-04-05 |
| HUGHES, Ellie | Director | 1999-08-16 | 2004-05-20 |
| JONES, Louis Philip | Director | 2010-08-24 | 2012-02-29 |
| MACPHAIL, Bruce Ian | Director | 1999-08-16 | 2003-08-15 |
| MCVEY, Donna, Dr | Director | 2003-09-17 | 2009-12-31 |
| MOUNT, Jacqueline Ann | Director | 2012-02-24 | 2022-05-31 |
| NORDKAMP, Hendrikus Hermannus | Director | 2015-02-25 | 2019-05-15 |
| NOSEWORTHY, Darren | Director | 2015-07-24 | 2017-01-09 |
| OSBORN, Ben John | Director | 2019-04-29 | 2022-02-28 |
| POULTON, Steven Michael | Director | 2009-11-04 | 2013-01-07 |
| REACHER, Paul Anthony | Director | 1996-02-19 | 2001-10-03 |
| REIDLA, Meelis | Director | 2016-05-12 | 2018-03-23 |
| RIENOW, Susan | Director | 2022-02-28 | 2024-10-08 |
| ROGERS, Douglas Anthony | Director | 2005-12-14 | 2008-08-29 |
| ROSE, Paul Richard | Director | 2018-03-23 | 2020-04-26 |
| SCORER, Harriet Jane Middleton, Dr | Director | 1993-09-01 | 2003-05-30 |
| SMITH, John Richard | Director | 2003-12-19 | 2015-02-25 |
| STAFFORD, John Rogers | Director | — | 2002-03-21 |
| TICHIAS, Ian Alan | Director | 2007-08-10 | 2013-04-22 |
| VERRINDER, Anne Lucille | Director | 2010-03-29 | 2017-07-06 |
| WALLCRAFT, Susan Jean | Director | 2009-11-04 | 2011-04-06 |
| WIINBERG, Ulf Arne | Director | 2002-07-15 | 2005-10-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Pfizer Inc | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 243 total filings
Material constitutional events — rename, articles re-file, resolution
- 2021-11-18 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-05 | AA | accounts | Accounts with accounts type full | |
| 2025-04-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-08 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-08 | AA | accounts | Accounts with accounts type full | |
| 2024-05-10 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-22 | AA | accounts | Accounts with accounts type full | |
| 2023-04-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-06-10 | AA | accounts | Accounts with accounts type full | |
| 2022-05-31 | TM01 | officers | Termination director company with name termination date | |
| 2022-04-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-03-09 | AP01 | officers | Appoint person director company with name date | |
| 2022-03-01 | TM01 | officers | Termination director company with name termination date | |
| 2021-11-18 | RESOLUTIONS | resolution | Resolution | |
| 2021-08-18 | AA | accounts | Accounts with accounts type full | |
| 2021-04-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-02-10 | TM01 | officers | Termination director company with name termination date | |
| 2021-02-09 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-11-30 vs 2023-11-30
-
Turnover
—
Not reported
-
Cash
0%
£246,000 £246,000
-
Net assets
+3.7%
£4,570,000 £4,738,000
-
Employees
—
Not reported
-
Operating profit
+90.1%
-£141,000 -£14,000
-
Profit before tax
+2.3%
£217,000 £222,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers